Octarine Bio

Startup
Summarized by Halo AI

Octarine Bio is a synthetic biology platform company that uses cell-factory engineering and precision fermentation to create sustainable, bio-based ingredients like dyes and skincare compounds to replace traditional, polluting industrial processes.

Founded & HQ
Copenhagen, Denmark
Company size
11-50 employees
Funding
~$13.9M
IP status
2 patents filed · 1 grant confirmed
Activity highlights
Secured €5 million in January 2026 to complete its €12.8 million Series A funding round for scaling its bio-based pigment platform, PurePalette.

Octarine Bio is a synthetic biology company based in Copenhagen, Denmark, that specializes in cell-factory engineering and precision fermentation to develop sustainable, bio-based ingredients. Founded in 2018, the company leverages proprietary technology to design custom microbes capable of producing high-value molecules, including textile dyes, skincare ingredients, and health supplements. By focusing on renewable resources and innovative biological processes, Octarine aims to provide alternatives to traditional, environmentally taxing manufacturing methods in industries such as textiles and personal care. The company’s core scientific expertise is rooted in foundational research conducted at the University of Copenhagen and the Technical University of Denmark.

The company’s flagship platform, PurePalette, offers a sustainable, non-toxic alternative to synthetic dyes used in the textile industry. This drop-in solution is designed to integrate seamlessly into existing supply chains, allowing manufacturers to reduce energy and water consumption while maintaining high performance. Beyond dyes, Octarine Bio engages in collaborative partnerships—such as with Ginkgo Bioworks—to scale its microbial production capabilities. By developing advanced enzyme technology to modify and enhance natural ingredients, the company seeks to address global sustainability challenges and provide scalable, value-added products for commercial partners. Octarine Bio has successfully secured significant venture capital funding to support the industrial-scale validation and commercial launch of its technologies.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.